Lundbeck expresses interest in acquiring Xeris Biopharma, Bloomberg reports
Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma, Bloomberg News reported, citing people familiar with the matter.
Sept 29 (Reuters) — Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma, Bloomberg News reported on Tuesday, citing people familiar with the matter. (Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar) ((Christy.Santhosh@thomsonreuters.com;)